Scarica l'app Stockscreener
0.826
4.56%
0.036
Dopo l'orario di chiusura:
.81
-0.016
-1.94%
Cue Biopharma Inc Borsa (CUE) Ultime notizie
Cue Biopharma Inc. stock daily chart insightsJuly 2025 Update & Consistent Profit Alerts - Newser
Order flow analysis tools used on Cue Biopharma Inc.July 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - Newser
What technical models suggest about Cue Biopharma Inc.’s comeback - Newser
Evaluating Cue Biopharma Inc. with trendline analysisEarnings Risk Summary & High Accuracy Trade Signal Alerts - Newser
Will Cue Biopharma Inc. stock benefit from interest rate changes2025 Market Overview & Growth Focused Investment Plans - Newser
Cue Biopharma Reports Q2 2025 Earnings: Collaboration Revenue Exceeds Estimate, Net Loss Narrows - AInvest
Intrinsic Value of Cue Biopharma Inc. Stock: Is It Undervalued or OvervaluedJuly 2025 Short Interest & Weekly Stock Performance Updates - Newser
Using AI based signals to follow Cue Biopharma Inc.July 2025 Trends & Verified Momentum Watchlists - Newser
Will Cue Biopharma Inc. stock go up soonWeekly Trade Report & Long-Term Growth Stock Strategies - Newser
Why Cue Biopharma Inc. stock is on top investor watchlistsWeekly Loss Report & Verified Stock Trade Ideas - Newser
Cue Biopharma's Q2 2025 Earnings Beat and Revenue Growth: A Glimpse of Sustainable Turnaround Potential? - AInvest
Why Cue Biopharma Inc. stock attracts strong analyst attentionIndex Update & AI Enhanced Trading Alerts - Newser
News impact scoring models applied to Cue Biopharma Inc.Weekly Gains Summary & AI Optimized Trade Strategies - Newser
Cue Biopharma Announces Initiation of Investigator Sponsored Tri - GuruFocus
Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme - The Manila Times
Dana-Farber Launches Trial of New Immunotherapy Drug for Aggressive Brain Cancer - Stock Titan
Cue Biopharma Inc. Facing Inflection Point in Trend Analysis2025 Buyback Activity & Weekly Top Performers Watchlists - sundaytimes.kr
Cue Biopharma Inc. stock daily chart insights [July 2025 Recap]Consistent Profit Trade Alerts - Newser
Cue Biopharma 2025 Q2 Earnings Narrowed Losses with Modest Revenue Growth - AInvest
Can machine learning forecast Cue Biopharma Inc. recoveryFree Risk Controlled Picks With Real Returns - Newser
Advanced analytics toolkit walkthrough for Cue Biopharma Inc.Trade Exit Summary & AI Based Buy and Sell Signals - Newser
How sentiment analysis helps forecast Cue Biopharma Inc.Risk-Managed Strategy Based on Price Analysis - Newser
Short interest data insights for Cue Biopharma Inc.Free Consistent Gain Investment Strategies - Newser
Cue Biopharma earnings beat by $0.05, revenue topped estimates - Investing.com Canada
Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Cue Biopharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
CUE BIOPHARMA Earnings Results: $CUE Reports Quarterly Earnings - Quiver Quantitative
Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights | CUE Stock News - GuruFocus
Cue Biopharma Advances Drug Development with FDA Feedback and Collaboration with Boehringer Ingelheim, Raises $20 Million in Public Offering - Quiver Quantitative
Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Stock Titan
Custom Dashboard Highlights Cue Biopharma Inc. Price MomentumInvestment Strategy With Predictable Gains Outlined - 선데이타임즈
How to recover losses in Cue Biopharma Inc. stockSecure Asset Flow and Trend Pattern Analysis - Newser
How moving averages guide Cue Biopharma Inc. tradingShort-Term Market Movement Forecast Report - Newser
Earnings visualization tools for Cue Biopharma Inc.Alpha Stock Picks with Chart Confirmation - Newser
Cue Biopharma (CUE) to Release Earnings on Wednesday - Defense World
How Cue Biopharma Inc. stock performs during market volatilityCapital Protection Strategy With Risk Analysis - Newser
How to read the order book for Cue Biopharma Inc.Weekly Trend Watch with Market Signals - Newser
Is Cue Biopharma Inc. stock overvalued or fairly pricedSkyrocketing Stock Opportunities - classian.co.kr
Trendlines Suggest Cue Biopharma Inc. May Bottom Out SoonProfit Target Stock Opportunity Monitor Activated - beatles.ru
Intraday pattern recognizer results for Cue Biopharma Inc.Free Weekly Stock Watch With Growth Focus - Newser
Published on: 2025-08-11 01:12:05 - Newser
Real time scanner hits for Cue Biopharma Inc. explainedFree Trade Setups With AI Powered Filters - Newser
Cue Biopharma Inc. Building a Base Near SupportWeekly Top Gainers Forecast Watchlist Released - beatles.ru
What makes Cue Biopharma Inc. stock price move sharplySmart Trend Analysis With Buy Point Cues - Newser
Leading vs lagging indicators on Cue Biopharma Inc. performanceFree Fundamental + Technical Hybrid Stock Tips - Newser
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):